Fig. 7
Antitumor efficacy analysis. (A) An overview diagram of the therapeutic protocols applied in the study. (B) Tumor volumes across different treatment groups (n = 6 mice per group) were analyzed with two-way ANOVA performed through Prism software. (C) Tumor suppression rates post-treatment for each group (n = 6 mice per group), analyzed using Prism software with one-way ANOVA. (D) Average tumor weights in various treatment groups (n = 6 mice per group), analyzed using Prism software with one-way ANOVA. (E) Survival rates of mice in each group following treatment, analyzed using Prism software with one-way ANOVA (n = 6 mice per group). (F) Body weight measurements of each treatment group were taken every 4 days until day 39(n = 6 mice/group), and analysis was done by prism software (two-way ANOVA). Assessment of liver enzyme activity of each treated mice group at day 39, G: alanine aminotransferase (ALT) and (H) aspartate aminotransferase (AST), analysis was done by prism software (two-way ANOVA, n = 6, mean ± SEM ****P < 000.1, ***P = 0.0006, **P = 0.0037, *P = 0.0260 and ns = not significant.
